Literature DB >> 8299206

Reperfusion injury after myocardial infarction: the role of free radicals and the inflammatory response.

K S Kilgore1, B R Lucchesi.   

Abstract

Development of thrombolytic therapy as a treatment for myocardial infarction has focused attention on the events that occur upon reperfusion of ischemic myocardial tissue. Although it is well documented that salvage of the ischemic myocardium is dependent upon timely reperfusion, it is likely that the very events critical for survival may, in fact, lead to further tissue injury. A widely recognized source of reperfusion injury is the generation of oxygen-derived free radicals. These reactive oxygen species, which are formed within the first moments of reperfusion, are known to be cytotoxic to surrounding cells. In addition, strong support exists for the involvement of the inflammatory system in mediating tissue damage upon reperfusion. Coincident with the recruitment of neutrophils and activation of the complement system is an increase in the loss of viable cells. Although a number of mechanisms are likely to be involved in reperfusion injury, this discussion focuses on the roles that oxygen-derived free radicals and the inflammatory system play in mediating reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8299206     DOI: 10.1016/0009-9120(93)90112-j

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  10 in total

1.  Does Reperfusion Injury Exist?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

2.  Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts.

Authors:  Wei Chen; Amit Saxena; Na Li; Jinyu Sun; Amit Gupta; Dong-Wook Lee; Qi Tian; Marcin Dobaczewski; Nikolaos G Frangogiannis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-20       Impact factor: 8.311

3.  Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease.

Authors:  L Lih-Brody; S R Powell; K P Collier; G M Reddy; R Cerchia; E Kahn; G S Weissman; S Katz; R A Floyd; M J McKinley; S E Fisher; G E Mullin
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

4.  Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling.

Authors:  Jiahui Yu; Lingyan Wang; Mary Akinyi; Yuhong Li; Zhenzhen Duan; Yan Zhu; Guanwei Fan
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 5.  Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment.

Authors:  C de Zwaan; M J A P Daemen; W Th Hermens
Journal:  Neth Heart J       Date:  2001-04       Impact factor: 2.380

Review 6.  State of the art in therapeutic hypothermia.

Authors:  Joshua W Lampe; Lance B Becker
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

7.  Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury.

Authors:  Kaliyamurthi Venkatachalam; Sumanth D Prabhu; Venkatapuram Seenu Reddy; William H Boylston; Anthony J Valente; Bysani Chandrasekar
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

8.  Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion.

Authors:  Robert A Matthijsen; Dennis Huugen; Nicole T Hoebers; Bart de Vries; Carine J Peutz-Kootstra; Yasuaki Aratani; Mohamed R Daha; Jan Willem Cohen Tervaert; Wim A Buurman; Peter Heeringa
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

9.  Effect of Ligusticum wallichii aqueous extract on oxidative injury and immunity activity in myocardial ischemic reperfusion rats.

Authors:  Qiao Zengyong; Ma Jiangwei; Liu Huajin
Journal:  Int J Mol Sci       Date:  2011-03-18       Impact factor: 5.923

10.  Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system.

Authors:  Ramón Rodrigo
Journal:  Front Physiol       Date:  2012-04-12       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.